Stocksigma LogoStocksigma Logo

IOL Chemicals & Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26

■ Revenue: 795 (+40.1% YoY | +5.1% QoQ) ■ EBITDA: 109 (+91.7% YoY | +5.7% QoQ) ■ EBITDA Margin (%): 13.8 (+371 bps YoY | +8 bps QoQ) ■ PAT: 65.1 (+117.1%

IOL Chemicals & Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26

IOL Chemicals & Pharmaceuticals Ltd · Financial Result · 30 Oct 2026, 11:29 pm

IOL Chemicals & Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore) ■ Revenue: 795 (+40.1% YoY | +5.1% QoQ) ■ EBITDA: 109 (+91.7% YoY | +5.7% QoQ) ■ EBITDA Margin (%): 13.8 (+371 bps YoY | +8 bps QoQ) ■ PAT: 65.1 (+117.1% YoY | +1.0% QoQ) ■ EPS (INR): 2.22 (+117.6% YoY | +1.4% QoQ) IOL Chemicals & Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore) Segmental Performance Pharmaceutical ■ Revenue: 473 (+40.5% YoY | +0.7% QoQ) ■ EBIT: 68.1 (+92.0% YoY | -1.1% QoQ) ■ EBIT Margin (%): 14.4 (+386 bps YoY | -26 bps QoQ) Chemical ■ Revenue: 394 (+38.3% YoY | +8.1% QoQ) ■ EBIT: 23.2 (+359.0% YoY | +33.8% QoQ) ■ EBIT Margin (%): 5.9 (+411 bps YoY | +113 bps QoQ)

Original exchange filing (PDF)

More announcements from IOL Chemicals & Pharmaceuticals Ltd

All IOL Chemicals & Pharmaceuticals Ltd announcements